Global Blood Transfusion Diagnostics Market Opportunities 2024 , Forecast To 2033
7 Mar, 2024
The blood transfusion diagnostics market has grown rapidly, increasing from $3.98 billion in 2023 to $4.42 billion in 2024 at a CAGR of 11.1%. This growth is fueled by factors such as increasing blood transfusions and the rising prevalence of chronic diseases. Projections suggest continued growth, with the market reaching $6.04 billion in 2028, reflecting a CAGR of 8.1%. Factors driving this growth include rising demand for precision medicine and advancements in diagnostics, with major trends including point-of-care testing and expanded pathogen panels.
Global Blood Transfusion Diagnostics Market Key Driver
Patients undergoing surgical procedures need a blood transfusion to replace the lost blood during the procedure. Blood transfusion diagnostics are used during the procedures to screen the blood before transferring it to the patient and will otherwise increase the incidence of infectious disease. According to an article published in the US National Library of Medicine, National Institutes of Health, approximately 310 million surgeries are being performed each year. This increase in the number of procedures will thereby drive the need for blood transfusion diagnostics.
Get A Free Sample Of The Global Blood Transfusion Diagnostics Market ReportGlobal Blood Transfusion Diagnostics Market Segments
The blood transfusion diagnostics market covered in this report is segmented –
1) By Type: Instruments and Kits, Reagents, Other Types
2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test
3) By Application: Blood Grouping, Disease Screening
4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies
By Geography: The countries covered in the blood transfusion diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the blood transfusion diagnostics market in 2023. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Major Blood Transfusion Diagnostics Industry Players
BAG Health Care GmbH; Grifols S.A.; Bio-Rad LaboratoriesInc.; Abbott Laboratories; Immucor Inc.; Ortho Clinical Diagnostics; DiaSorin S.p.A; Siemens Healthineers; Thermo Fisher Scientific Inc.; Beckman Coulter Inc.; Novartis AG; F. Hoffmann-La Roche Ltd.; Quotient Limited; HologicInc; Roche Diagnostics; bioMerieux; Diagast SAS; Fujirebio; Biokit S.A.; QuidelOrtho Corporation; Gen-Probe; Proteomes Sciences plc; Danaher Corporation; Immucor Inc.; Becton Dickinson and Company; Quotient Biodiagnostics; Thermo Fisher Scientific; Sekisui Diagnostics; Sysmex Corporation; Werfen S.A.
Get The Full Global Blood Transfusion Diagnostics Market Report
Blood Transfusion Diagnostics Market Overview
Blood transfusion diagnostics are used to conduct tests before the transfusion of blood from donor-recipient such as blood grouping disease screening.